Flippot, Ronan
Patrikidou, Anna
Aldea, Mihaela
Colomba, Emeline
Lavaud, Pernelle
Albigès, Laurence
Naoun, Natacha
Blanchard, Pierre
Terlizzi, Mario
Garcia, Camilo
Bernard-Tessier, Alice
Fuerea, Alina
Di Palma, Mario
Escudier, Bernard
Loriot, Yohann
Baciarello, Giulia
Fizazi, Karim
Article History
Accepted: 10 March 2022
First Online: 5 May 2022
Declarations
:
: No external funding was used in the preparation of this manuscript.
: Ronan Flippot has received honoraria from Janssen, Ipsen, Bristol-Myers Squibb, MSD, and Pfizer, and has received travel expenses from Merck. Anna Patrikidou has received consulting fees from Basilea. Mihaela Aldea has received travel expenses from Sandoz. Emeline Colomba is a member of the Advisory Boards of Bristol-Myers Squibb, Ipsen, Sanofi, Glaxo-Smith Kline, MSD, Pfizer, Clovis, Novartis, and Eisai. Pernelle Lavaud has received travel expenses from Astellas, Ipsen, Janssen, and Mundipharma. Laurence Albigès has received consulting fees from Amgen, Astellas, AstraZeneca, Bristol-Myers Squibb, Corvus Pharmaceuticals, Exelixis, Ipsen, Janssen, Merck, MSD, Novartis, Peloton Therapeutics, Pfizer, and Roche; research funding from Bristol-Myers Squibb; and travel expenses from Bristol-Myers Squibb and MSD. Bernard Escudier has received honoraria from Bristol-Myers Squibb, EUSA Pharma, Ipsen, Novartis, Oncorena, Pfizer, and Roche/Genentech; consulting or advisory role fees from AVEO, Bristol-Myers Squibb, EUSA Pharma, Ipsen, Novartis, Pfizer, and Roche/Genentech; research funding from Bristol-Myers Squibb; and travel, accommodations and expenses from Bristol-Myers Squibb, Ipsen, MSD, Pfizer, and Roche/Genentech. Yohann Loriot has received honoraria from Pfizer and Sanofi; consulting or advisory role fees from Astellas Pharma, AstraZeneca, Bristol-Myers Squibb, Clovis Oncology, Janssen, MSD Oncology, Roche, Seattle Genetics; research funding from AstraZeneca, Boehringer Ingelheim, Clovis Oncology, CureVac, Exelixis, Incyte, Janssen Oncology, Medivation, MSD Oncology, Nektar, Oncogenex, Pfizer, and Sanofi; and travel, accommodations and expenses from Astellas Pharma, AstraZeneca, Janssen Oncology, MSD Oncology, Roche, and Seattle Genetics. Giulia Baciarello has received honoraria from Astellas Pharma, Janssen Oncology, Roche, and Sanofi; consulting or advisory role fees from Astellas Pharma, Europharma, Janssen Oncology, Modra Pharmaceuticals, Roche, Sanofi, Simon-Kucher and Partners; and travel, accommodations and expenses from Amgen, Astellas Pharma, AstraZeneca, Ipsen, Janssen Oncology, and Sanofi. Karim Fizazi has received advisory fees from Amgen, Astellas, Astrazeneca, Bayer, Clovis, Janssen, MSD, Novartis/AAA, Sanofi, CureVac, and Orion. Natacha Naoun, Pierre Blanchard, Mario Terlizzi, Camilo Garcia, Alice Bernard-Tessier, Alina Fuerea, and Mario Di Palma have no conflicts of interest to declare.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
: Data collection: Mihaela Aldea, Anna Patrikidou, Giulia Baciarello, Ronan Flippot. Data analysis, redaction, proofing: all authors.